Skip to content

PRECISION OPTICS CORPORATION, INC.

NASDAQ: POCI

Company: Precision Optics Corporation
Ticker: Nasdaq: POCI
Sector: Technology
Investor Contact: Robert Blum

Precision Optics Corporation Financials

Financials – Current & Historical

CONSOLIDATED BALANCE SHEETS (UNAUDITED)
v3.25.0.1
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Dec. 31, 2024
Jun. 30, 2024
Current Assets:    
Cash and cash equivalents $ 212,441 $ 405,278
Accounts receivable, net of allowance for credit losses of $121,901 at December 31, 2024 and $118,872 at June 30, 2024 3,506,395 3,545,491
Inventories, net 3,847,827 2,868,100
Prepaid expenses 275,041 299,364
Total current assets 7,841,704 7,118,233
Fixed Assets:    
Machinery and equipment 3,292,852 3,341,194
Leasehold improvements 823,191 810,914
Furniture and fixtures 506,660 416,425
Total fixed assets 4,622,703 4,568,533
Less—accumulated depreciation and amortization 4,172,446 4,074,960
Net fixed assets 450,257 493,573
Operating lease right-to-use asset 101,946 189,999
Patents, net 292,474 286,559
Goodwill 8,824,210 8,824,210
Total other assets 9,218,630 9,300,768
TOTAL ASSETS 17,510,591 16,912,574
Current Liabilities:    
Revolving line of credit 900,000 1,000,000
Current portion of capital lease obligation 36,622 41,113
Current maturities of long-term debt 427,763 276,928
Accounts payable 2,738,104 1,397,313
Contract liabilities 1,417,933 1,172,350
Accrued compensation and other 791,037 840,662
Operating lease liability 101,946 178,450
Total current liabilities 6,413,405 4,906,816
Capital lease obligation, net of current portion 9,270 27,369
Long-term debt, net of current maturities and debt issuance costs 1,611,944 1,899,052
Operating lease liability, net of current portion 0 11,549
Total liabilities 8,034,619 6,844,786
Stockholders’ Equity:    
Common stock, $0.01 par value: 50,000,000 shares authorized; issued and outstanding – 6,355,534 shares at December 31, 2024 and 6,073,939 at June 30, 2024 63,555 60,739
Additional paid-in capital 62,883,729 61,197,433
Accumulated deficit (53,471,312) (51,190,384)
Total stockholders’ equity 9,475,972 10,067,788
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 17,510,591 $ 16,912,574
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (PARENTHETICAL)
v3.25.0.1
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)
Dec. 31, 2024
Jun. 30, 2024
Statement of Financial Position [Abstract]    
Allowance for credit losses $ 121,901 $ 118,872
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 50,000,000 50,000,000
Common stock, shares issued 6,355,534 6,073,939
Common stock, shares outstanding 6,355,534 6,073,939
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]        
Revenues $ 4,526,907 $ 4,824,289 $ 8,723,960 $ 9,145,544
Cost of Goods Sold 3,456,965 3,373,313 6,536,688 6,230,957
Gross Profit 1,069,942 1,450,976 2,187,272 2,914,587
Research and Development Expenses 317,747 221,728 718,406 434,486
Selling, General and Administrative Expenses 1,662,216 1,933,410 3,625,828 3,589,556
Total Operating Expenses 1,979,963 2,155,138 4,344,234 4,024,042
Operating Income (Loss) (910,021) (704,162) (2,156,962) (1,109,455)
Interest Expense (59,660) (54,640) (123,966) (113,762)
Net Income (Loss) $ (969,681) $ (758,802) $ (2,280,928) $ (1,223,217)
Income (Loss) Per Share:        
Income Loss Per Share, Basic $ (0.15) $ (0.13) $ (0.36) $ (0.20)
Income Loss Per Share, Fully diluted $ (0.15) $ (0.13) $ (0.36) $ (0.20)
Weighted average common shares outstanding, Basic 6,350,403 6,066,572 6,283,516 6,066,545
Weighted average common shares outstanding, Fully diluted 6,350,403 6,066,572 6,283,516 6,066,545
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities:    
Net Income (Loss) $ (2,280,928) $ (1,223,217)
Adjustments to reconcile net loss to net cash used in by operating activities -    
Depreciation and amortization 97,486 104,261
Stock-based compensation expense 457,570 491,177
Non-cash interest expense 8,918 8,752
Changes in operating assets and liabilities -    
Accounts receivable, net 39,096 395,863
Inventories, net (979,727) (323,770)
Prepaid expenses 24,323 15,560
Accounts payable 1,340,791 (756,522)
Customer advances 245,583 (16,448)
Accrued compensation and other (58,543) (188,480)
Net cash used in operating activities (1,105,431) (1,492,824)
Cash Flows from Investing Activities:    
Purchases of fixed assets (54,170) (152,240)
Additional patent costs (5,915) (18,532)
Net cash used in investing activities (60,085) (170,772)
Cash Flows from Financing Activities:    
Payments of capital lease obligations (22,590) (21,282)
Payments of long-term debt (121,273) (256,630)
Payments of debt issuance costs (15,000) 0
Payments on line of credit (100,000) 0
Gross proceeds from private placements of common stock 1,204,542 0
Gross proceeds from the exercise of stock options 27,000 2,700
Net cash provided by (used in) financing activities 972,679 (275,212)
Net (decrease) increase in cash and cash equivalents (192,837) (1,938,808)
Cash and cash equivalents, beginning of period 405,278 2,925,852
Cash and cash equivalents, end of period $ 212,441 $ 987,044

Arrow